Benck, Urs, Hoeger, Simone, Brinkkoetter, Paul T., Gottmann, Uwe, Doenmez, Duygu, Boesebeck, Detlef, Lauchart, Werner, Gummert, Jan, Karck, Matthias, Lehmkuhl, Hans B., Bittner, Hartmuth B., Zuckermann, Andreas ORCID: 0000-0002-8054-8150, Wagner, Florian, Schulz, Uwe, Koch, Achim, Bigdeli, Amir K., Bara, Christoph, Hirt, Stephan, Berchtold-Herz, Michael, Brose, Stefan, Herold, Ulf, Boehm, Johannes, Welp, Henryk, Strecker, Thomas, Doesch, Andreas, Birck, Rainer, Kraemer, Bernhard K., Yard, Benito A. and Schnuelle, Peter (2011). Effects of Donor Pre-Treatment With Dopamine on Survival After Heart Transplantation A Cohort Study of Heart Transplant Recipients Nested in a Randomized Controlled Multicenter Trial. J. Am. Coll. Cardiol., 58 (17). S. 1768 - 1778. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1558-3597

Full text not available from this repository.

Abstract

Objectives We determined the outcome of cardiac allografts from multiorgan donors enrolled in a randomized trial of donor pre-treatment with dopamine. Background Treatment of the brain-dead donor with low-dose dopamine improves immediate graft function after kidney transplantation. Methods A cohort study of 93 heart transplants from 21 European centers was undertaken between March 2004 and August 2007. We assessed post-transplant left ventricular function (LVF), requirement of a left ventricular assist device (LVAD) or biventricular assist device (BVAD), need for hemofiltration, acute rejection, and survival of recipients of a dopamine-treated versus untreated graft. Results Donor dopamine was associated with improved survival 3 years after transplantation (87.0% vs. 67.8%, p = 0.03). Fewer recipients of a pre-treated graft required hemofiltration after transplant (21.7% vs. 40.4%, p = 0.05). Impaired LVF (15.2% vs. 21.3%, p = 0.59), requirement of a LVAD (4.4% vs. 10.6%, p = 0.44), and biopsy-proven acute rejection (19.6% vs. 14.9%, p = 0.59) were not statistically different between groups. Post-transplant impaired LVF (hazard ratio [HR]: 4.95; 95% confidence interval [CI]: 2.08 to 11.79; p < 0.001), requirement of LVAD (HR: 6.65; 95% CI: 2.40 to 18.45; p < 0.001), and hemofiltration (HR: 2.83; 95% CI: 1.20 to 6.69; p = 0.02) were predictive of death. The survival benefit remained (HR: 0.33; 95% CI: 0.12 to 0.89; p = 0.03) after adjustment for various risks affecting mortality, including pre-transplant LVAD/BVAD, inotropic support, and impaired kidney function. Conclusions Treatment of brain-dead donors with dopamine of 4 mu g/kg/min will not harm cardiac allografts but appears to improve the clinical course of the heart allograft recipient. (Prospective Randomized Trial to Evaluate the Efficacy of Donor Preconditioning With Dopamine on Initial Graft Function After Kidney Transplantation; NCT00115115) (J Am Coll Cardiol 2011;58:1768-77) (C) 2011 by the American College of Cardiology Foundation

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Benck, UrsUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hoeger, SimoneUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Brinkkoetter, Paul T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gottmann, UweUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Doenmez, DuyguUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boesebeck, DetlefUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lauchart, WernerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gummert, JanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Karck, MatthiasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lehmkuhl, Hans B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bittner, Hartmuth B.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Zuckermann, AndreasUNSPECIFIEDorcid.org/0000-0002-8054-8150UNSPECIFIED
Wagner, FlorianUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schulz, UweUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Koch, AchimUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bigdeli, Amir K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Bara, ChristophUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hirt, StephanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Berchtold-Herz, MichaelUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Brose, StefanUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Herold, UlfUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Boehm, JohannesUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Welp, HenrykUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Strecker, ThomasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Doesch, AndreasUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Birck, RainerUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Kraemer, Bernhard K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Yard, Benito A.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schnuelle, PeterUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-487196
DOI: 10.1016/j.jacc.2011.05.060
Journal or Publication Title: J. Am. Coll. Cardiol.
Volume: 58
Number: 17
Page Range: S. 1768 - 1778
Date: 2011
Publisher: ELSEVIER SCIENCE INC
Place of Publication: NEW YORK
ISSN: 1558-3597
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
COLD-PRESERVATION; RENAL DYSFUNCTION; DOSE DOPAMINE; INJURY; HYPOTHERMIA; PREDICTORS; THERAPY; CALCIUM; CELLSMultiple languages
Cardiac & Cardiovascular SystemsMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/48719

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item